<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="a recent possible exposure to SARS-CoV-2. For example, PEP with" exact="rifampicin" post="is given to people exposed to index cases of"/>
 <result pre="people exposed to index cases of invasive meningococcal infection, and" exact="oseltamivir" post="has been recommended by WHO for people at high"/>
 <result pre="concentrations and in vitro drug testing suggest that prophylaxis with" exact="hydroxychloroquine" post="at approved doses could prevent SARS-CoV-2 infection and ameliorate"/>
 <result pre="prevent SARS-CoV-2 infection and ameliorate viral shedding.5 Clinical trials of" exact="hydroxychloroquine" post="treatment for COVID-19 pneumonia are underway in China (NCT04261517"/>
 <result pre="anyone found to be infected, and the efficacy of prophylactic" exact="hydroxychloroquine" post="in preventing secondary SARS-CoV-2 infections and disease symptoms among"/>
 <result pre="1286 of their close contactsmedRxiv2020published online March 4.10.1101/2020.03.03.20028423(preprint). 3WelliverRMontoASCarewiczOEffectiveness of" exact="oseltamivir" post="in preventing influenza in household contacts: a randomized controlled"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
 <result pre="coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020published online March 9.10.1093/cid/ciaa237 5TettSECutlerDJDayROBrownKFBioavailability of" exact="hydroxychloroquine" post="tablets in healthy volunteersBr J Clin Pharmacol2719897717792757893 6Henao-RestrepoAMCamachoALonginiIMEfficacy and"/>
</results>
